$EYEN
EYENOVIA, INC.

2022 Q1 Form 10-Q Financial Statement

#000141057822001443 Filed on May 13, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $0.00 $2.000M
YoY Change -100.0%
Cost Of Revenue $0.00 $800.0K
YoY Change -100.0%
Gross Profit $0.00 $1.200M
YoY Change -100.0%
Gross Profit Margin 60.0%
Selling, General & Admin $3.475M $2.300M
YoY Change 51.09% 25.0%
% of Gross Profit 191.67%
Research & Development $3.713M $4.323M
YoY Change -14.11% 19.08%
% of Gross Profit 360.22%
Depreciation & Amortization $75.43K $33.28K
YoY Change 126.65% 10.94%
% of Gross Profit 2.77%
Operating Expenses $7.188M $6.567M
YoY Change 9.46% 20.05%
Operating Profit -$7.188M -$5.367M
YoY Change 33.93%
Interest Expense $145.2K $5.148K
YoY Change 2721.23% -74.26%
% of Operating Profit
Other Income/Expense, Net -$7.073K $18.59K
YoY Change -138.06%
Pretax Income -$7.340M -$5.350M
YoY Change 37.19% -1.83%
Income Tax
% Of Pretax Income
Net Earnings -$7.340M -$5.352M
YoY Change 37.15% -1.82%
Net Earnings / Revenue -267.58%
Basic Earnings Per Share -$0.24 -$0.21
Diluted Earnings Per Share -$0.24 -$0.21
COMMON SHARES
Basic Shares Outstanding 30.01M 25.33M
Diluted Shares Outstanding 30.01M 25.33M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.72M $24.91M
YoY Change 7.25% 82.36%
Cash & Equivalents $26.70M $24.91M
Short-Term Investments
Other Short-Term Assets $1.830M $1.940M
YoY Change -5.66% 151.95%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $30.40M $28.03M
YoY Change 8.45% 93.04%
LONG-TERM ASSETS
Property, Plant & Equipment $1.370M $710.0K
YoY Change 93.01% 162.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $119.0K
YoY Change
Other Assets $8.419M $120.0K
YoY Change 6915.89% 0.0%
Total Long-Term Assets $9.789M $820.0K
YoY Change 1093.83% 110.26%
TOTAL ASSETS
Total Short-Term Assets $30.40M $28.03M
Total Long-Term Assets $9.789M $820.0K
Total Assets $40.19M $28.85M
YoY Change 39.3% 93.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.535M $1.820M
YoY Change -15.67% 45.6%
Accrued Expenses $1.057M $1.730M
YoY Change -38.89% 113.58%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $780.0K
YoY Change -100.0% 85.71%
Long-Term Debt Due $7.740M $780.0K
YoY Change 892.32% 85.71%
Total Short-Term Liabilities $10.38M $16.37M
YoY Change -36.6% 544.49%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $310.0K
YoY Change -100.0%
Other Long-Term Liabilities $15.08K $40.00K
YoY Change -62.3% -20.0%
Total Long-Term Liabilities $15.08K $350.0K
YoY Change -95.69% 600.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.38M $16.37M
Total Long-Term Liabilities $15.08K $350.0K
Total Liabilities $10.39M $16.71M
YoY Change -37.8% 547.67%
SHAREHOLDERS EQUITY
Retained Earnings -$97.60M
YoY Change
Common Stock $3.171K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $29.79M $12.14M
YoY Change
Total Liabilities & Shareholders Equity $40.19M $28.85M
YoY Change 39.3% 93.49%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$7.340M -$5.352M
YoY Change 37.15% -1.82%
Depreciation, Depletion And Amortization $75.43K $33.28K
YoY Change 126.65% 10.94%
Cash From Operating Activities -$8.200M -$4.600M
YoY Change 78.26% -22.3%
INVESTING ACTIVITIES
Capital Expenditures $174.6K $344.3K
YoY Change -49.3% 266.57%
Acquisitions
YoY Change
Other Investing Activities -$33.10K
YoY Change
Cash From Investing Activities -$207.7K -$344.3K
YoY Change -39.69% 282.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 15.65M 1.453M
YoY Change 976.55% -73.67%
NET CHANGE
Cash From Operating Activities -8.200M -4.600M
Cash From Investing Activities -207.7K -344.3K
Cash From Financing Activities 15.65M 1.453M
Net Change In Cash 7.254M -3.465M
YoY Change -309.38% 607.1%
FREE CASH FLOW
Cash From Operating Activities -$8.200M -$4.600M
Capital Expenditures $174.6K $344.3K
Free Cash Flow -$8.375M -$4.944M
YoY Change 69.38% -17.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.21
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30008194
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25330563
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001682639
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31698424
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28426616
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-38365
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
EYENOVIA, INC.
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-1178401
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
295 Madison Avenue, Suite 2400
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
NEW YORK
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10017
CY2022Q1 dei City Area Code
CityAreaCode
917
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
289-1117
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 Par Value
CY2022Q1 dei Trading Symbol
TradingSymbol
EYEN
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33568554
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26716269
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19461850
CY2022Q1 eyen License Fee And Expense Reimbursements Receivables
LicenseFeeAndExpenseReimbursementsReceivables
1364309
CY2021Q4 eyen License Fee And Expense Reimbursements Receivables
LicenseFeeAndExpenseReimbursementsReceivables
1805065
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2318047
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
734942
CY2022Q1 us-gaap Assets Current
AssetsCurrent
30398625
CY2021Q4 us-gaap Assets Current
AssetsCurrent
22001857
CY2022Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
7875000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
7875000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1370359
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1271225
CY2022Q1 eyen Security Deposits
SecurityDeposits
119035
CY2021Q4 eyen Security Deposits
SecurityDeposits
119035
CY2022Q1 eyen Equipment Deposits
EquipmentDeposits
425036
CY2021Q4 eyen Equipment Deposits
EquipmentDeposits
391941
CY2022Q1 us-gaap Assets
Assets
40188055
CY2021Q4 us-gaap Assets
Assets
31659058
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1534764
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1614104
CY2022Q1 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
675394
CY2021Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
1543618
CY2022Q1 eyen Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
404707
CY2021Q4 eyen Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
845719
CY2022Q1 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
23780
CY2021Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
18685
CY2022Q1 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
7740120
CY2021Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
7150368
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
10378765
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11172494
CY2022Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
15080
CY2021Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
19949
CY2022Q1 us-gaap Liabilities
Liabilities
10393845
CY2021Q4 us-gaap Liabilities
Liabilities
11192443
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
6000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
6000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31698424
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28426616
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
3171
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2844
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
110683077
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-97558971
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
127350010
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-90219306
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
29794210
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
20466615
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40188055
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31659058
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2000000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
0
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
800000
CY2022Q1 us-gaap Gross Profit
GrossProfit
0
CY2021Q1 us-gaap Gross Profit
GrossProfit
1200000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3712584
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4322648
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3474965
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2243990
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
7187549
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
6566638
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7187549
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5366638
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7073
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18585
CY2022Q1 us-gaap Interest Expense
InterestExpense
145237
CY2021Q1 us-gaap Interest Expense
InterestExpense
5148
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
194
CY2021Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1534
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-7339665
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5351667
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30008194
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25330563
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
20466615
CY2022Q1 eyen Stock Issued During Period Value New Issues One
StockIssuedDuringPeriodValueNewIssuesOne
14897908
CY2022Q1 eyen Stock Issued At Market Offering During Period Value New Issues
StockIssuedAtMarketOfferingDuringPeriodValueNewIssues
860365
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
908987
CY2022Q1 eyen Restricted Stock Issued During Period Value New Issues
RestrictedStockIssuedDuringPeriodValueNewIssues
0
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-7339665
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
29794210
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
15303885
CY2021Q1 eyen Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
1530990
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
656913
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5351667
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
12140121
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-7339665
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5351667
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
908987
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
656913
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
75432
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33281
CY2022Q1 eyen Amortization Of Debt Discount
AmortizationOfDebtDiscount
26215
CY2021Q1 eyen Amortization Of Debt Discount
AmortizationOfDebtDiscount
0
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
907774
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
251091
CY2022Q1 eyen Increase Decrease In License Fee And Expense Reimbursements Receivables
IncreaseDecreaseInLicenseFeeAndExpenseReimbursementsReceivables
-440756
CY2021Q1 eyen Increase Decrease In License Fee And Expense Reimbursements Receivables
IncreaseDecreaseInLicenseFeeAndExpenseReimbursementsReceivables
-2057808
CY2022Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0
CY2021Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-800000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-79340
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
353452
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-868224
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-579940
CY2022Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-441012
CY2021Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-291600
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-2000000
CY2022Q1 eyen Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
226
CY2021Q1 eyen Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-1002
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8184399
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4573846
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
174567
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
344320
CY2022Q1 eyen Vendor Deposits For Property Plant And Equipment
VendorDepositsForPropertyPlantAndEquipment
33095
CY2021Q1 eyen Vendor Deposits For Property Plant And Equipment
VendorDepositsForPropertyPlantAndEquipment
0
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-207662
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-344320
CY2022Q1 eyen Proceeds From Sale Of Common Stock And Warrants In Registered Direct Offering
ProceedsFromSaleOfCommonStockAndWarrantsInRegisteredDirectOffering
14981299
CY2021Q1 eyen Proceeds From Sale Of Common Stock And Warrants In Registered Direct Offering
ProceedsFromSaleOfCommonStockAndWarrantsInRegisteredDirectOffering
0
CY2022Q1 eyen Proceeds From Issuance Of Common Stock At Market Offering
ProceedsFromIssuanceOfCommonStockAtMarketOffering
-860365
CY2021Q1 eyen Proceeds From Issuance Of Common Stock At Market Offering
ProceedsFromIssuanceOfCommonStockAtMarketOffering
0
CY2022Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1530990
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
111793
CY2021Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
77604
CY2022Q1 eyen Payments For Repurchase Of Public Offering
PaymentsForRepurchaseOfPublicOffering
83391
CY2021Q1 eyen Payments For Repurchase Of Public Offering
PaymentsForRepurchaseOfPublicOffering
0
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15646480
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1453386
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7254419
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3464780
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27336850
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28371828
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34591269
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24907048
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26716269
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24907048
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7875000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34591269
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24907048
CY2022Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
95585
CY2021Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
3997
CY2022Q1 eyen Purchase Of Insurance Premium Financed By Short Term Note Payable
PurchaseOfInsurancePremiumFinancedByShortTermNotePayable
675331
CY2021Q1 eyen Purchase Of Insurance Premium Financed By Short Term Note Payable
PurchaseOfInsurancePremiumFinancedByShortTermNotePayable
705360
CY2022Q1 eyen Issuance Of Common Stock Related To Vested Restricted Stock Units
IssuanceOfCommonStockRelatedToVestedRestrictedStockUnits
2
CY2022Q1 eyen Percentage Of Success Rate Of Optejet
PercentageOfSuccessRateOfOptejet
0.90
CY2022Q1 eyen Percentage Of Successful Rate Of Traditional Eye Drops
PercentageOfSuccessfulRateOfTraditionalEyeDrops
0.50
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26700000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-97600000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-7300000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-5400000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8200000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4600000
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
7875000
CY2022Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
26466269
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
19211850
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12847777
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4900969
CY2022Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Reclassifications</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Certain prior period balances have been reclassified in order to conform to current period presentation. These reclassifications have no effect on previously reported results of operations or loss per share.</p>
CY2022Q1 us-gaap Prepaid Insurance
PrepaidInsurance
965631
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
171370
CY2022Q1 eyen Payroll Taxes Receivable
PayrollTaxesReceivable
487910
CY2021Q4 eyen Payroll Taxes Receivable
PayrollTaxesReceivable
343785
CY2022Q1 eyen Clinical Supply Deferred Costs
ClinicalSupplyDeferredCosts
336438
CY2021Q4 eyen Clinical Supply Deferred Costs
ClinicalSupplyDeferredCosts
0
CY2022Q1 eyen Prepaid Professional Fees
PrepaidProfessionalFees
120000
CY2021Q4 eyen Prepaid Professional Fees
PrepaidProfessionalFees
0
CY2022Q1 eyen Prepaid General And Administrative Expenses
PrepaidGeneralAndAdministrativeExpenses
99874
CY2021Q4 eyen Prepaid General And Administrative Expenses
PrepaidGeneralAndAdministrativeExpenses
71375
CY2022Q1 eyen Prepaid Director Fees Current
PrepaidDirectorFeesCurrent
95000
CY2021Q4 eyen Prepaid Director Fees Current
PrepaidDirectorFeesCurrent
66250
CY2022Q1 eyen Prepaid Conference Expenses
PrepaidConferenceExpenses
89627
CY2021Q4 eyen Prepaid Conference Expenses
PrepaidConferenceExpenses
12586
CY2022Q1 eyen Prepaid Patent Expense
PrepaidPatentExpense
53266
CY2021Q4 eyen Prepaid Patent Expense
PrepaidPatentExpense
32797
CY2022Q1 eyen Prepaid Rent And Security Deposit
PrepaidRentAndSecurityDeposit
36722
CY2021Q4 eyen Prepaid Rent And Security Deposit
PrepaidRentAndSecurityDeposit
32254
CY2022Q1 us-gaap Other Assets
OtherAssets
33579
CY2021Q4 us-gaap Other Assets
OtherAssets
4525
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2318047
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
734942
CY2021Q4 eyen Accrued Franchise Tax
AccruedFranchiseTax
1680
CY2022Q1 eyen Accrued Travel And Entertainment Expenses Current
AccruedTravelAndEntertainmentExpensesCurrent
5548
CY2022Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
332563
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1245795
CY2022Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
342831
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
297823
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
675394
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1543618
CY2022Q1 eyen Accrued Consulting And Professional Services Current
AccruedConsultingAndProfessionalServicesCurrent
208325
CY2021Q4 eyen Accrued Consulting And Professional Services Current
AccruedConsultingAndProfessionalServicesCurrent
250000
CY2022Q1 us-gaap Interest Payable Current
InterestPayableCurrent
118230
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
94792
CY2022Q1 eyen Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
36667
CY2021Q4 eyen Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
436840
CY2022Q1 eyen Credit Card Payable
CreditCardPayable
19558
CY2021Q4 eyen Credit Card Payable
CreditCardPayable
20000
CY2022Q1 eyen Accrued Franchise Tax
AccruedFranchiseTax
13100
CY2021Q4 eyen Accrued Travel And Entertainment Expenses Current
AccruedTravelAndEntertainmentExpensesCurrent
0
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3279
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
42407
CY2022Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
404707
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
845719
CY2022Q1 us-gaap Notes Payable
NotesPayable
8063538
CY2022Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
323418
CY2022Q1 eyen Notes Payable Net Of Debt Discount Total
NotesPayableNetOfDebtDiscountTotal
7740120
CY2021Q4 us-gaap Notes Payable
NotesPayable
7500000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
349632
CY2021Q4 eyen Notes Payable Net Of Debt Discount Total
NotesPayableNetOfDebtDiscountTotal
7150368
CY2022Q1 us-gaap Supplemental Unemployment Benefits Salary Continuation
SupplementalUnemploymentBenefitsSalaryContinuation
1331000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
908987
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
656913
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
41778
CY2021Q4 eyen Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Non Vested Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsNonVestedOutstandingWeightedAverageExercisePrice
3.59
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
13926
CY2022Q1 eyen Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice
3.10
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
6963
CY2022Q1 eyen Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Forfeited In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsForfeitedInPeriodWeightedAverageExercisePrice
3.59
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
48741
CY2022Q1 eyen Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Non Vested Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsNonVestedOutstandingWeightedAverageExercisePrice
3.45
CY2022Q1 eyen Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested Rs Us Undelivered Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedRSUsUndeliveredNumber
66588
CY2022Q1 eyen Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Vested Rs Us Undelivered Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsVestedRSUsUndeliveredWeightedAverageExercisePrice
3.85
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M6D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0092
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.94
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2022Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
4774473
CY2022Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P6Y8M12D
CY2022Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
2962028
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
5295408
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y10M24D
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1217715
CY2021Q4 eyen Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
2.69
CY2022Q1 eyen Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
6740260
CY2022Q1 eyen Class Of Warrant Or Right Granted Weighted Average Exercise Price
ClassOfWarrantOrRightGrantedWeightedAverageExercisePrice
2.56
CY2022Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
7957975
CY2022Q1 eyen Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
2.58
CY2022Q1 eyen Class Of Warrant Or Right Outstanding Weighted Average Remaining Life
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingLife
P3Y9M18D
CY2022Q1 eyen Class Of Warrant Or Right Outstanding Aggregate Intrinsic Value
ClassOfWarrantOrRightOutstandingAggregateIntrinsicValue
6283580
CY2022Q1 eyen Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
3087845
CY2022Q1 eyen Class Of Warrant Or Right Exercisable Weighted Average Exercise Price
ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice
1.07
CY2022Q1 eyen Class Of Warrant Or Right Exercisable Weighted Average Remaining Life
ClassOfWarrantOrRightExercisableWeightedAverageRemainingLife
P3Y6M
CY2022Q1 eyen Class Of Warrant Or Right Exercisable Aggregate Intrinsic Value
ClassOfWarrantOrRightExercisableAggregateIntrinsicValue
6283580
CY2022Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
7957975
CY2022Q1 eyen Class Of Warrant Or Right Exercisable Weighted Average Remaining Life
ClassOfWarrantOrRightExercisableWeightedAverageRemainingLife
P3Y6M
CY2022Q1 eyen Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
3087845
CY2019Q2 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
CY2019Q2 us-gaap Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage
DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
0.04
CY2022Q1 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
86099
CY2021Q1 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
64178

Files In Submission

Name View Source Status
0001410578-22-001443-index-headers.html Edgar Link pending
0001410578-22-001443-index.html Edgar Link pending
0001410578-22-001443.txt Edgar Link pending
0001410578-22-001443-xbrl.zip Edgar Link pending
eyen-20220331.xsd Edgar Link pending
eyen-20220331x10q.htm Edgar Link pending
eyen-20220331x10q_htm.xml Edgar Link completed
eyen-20220331xex31d1.htm Edgar Link pending
eyen-20220331xex31d2.htm Edgar Link pending
eyen-20220331xex32d1.htm Edgar Link pending
eyen-20220331xex32d2.htm Edgar Link pending
eyen-20220331_cal.xml Edgar Link unprocessable
eyen-20220331_def.xml Edgar Link unprocessable
eyen-20220331_lab.xml Edgar Link unprocessable
eyen-20220331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending